Working… Menu

Tocilizumab in Patients With Schnitzler's Syndrome (TOCISCH)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT03046381
Recruitment Status : Recruiting
First Posted : February 8, 2017
Last Update Posted : January 31, 2019
Roche Pharma AG
Information provided by (Responsible Party):
Karoline Krause, Charite University, Berlin, Germany

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : July 31, 2019
Estimated Study Completion Date : July 31, 2019